DelistingApr 22, 2026, 05:21 PM
Tevogen Bio Fails Nasdaq Listing Rules, Faces Delisting Risk
AI Summary
Tevogen Bio Holdings Inc. received two letters from Nasdaq's Listing Qualifications Department, notifying the company that it no longer meets the $50 million minimum market value for listed securities and the $15 million minimum market value of publicly held shares requirements. These notifications are based on the company's market value over the previous 30 consecutive business days. The company has been granted 180 calendar days to regain compliance with both requirements, with deadlines of October 13, 2026, and October 14, 2026, respectively.
Key Highlights
- Tevogen Bio failed Nasdaq's $50M minimum market value for listed securities.
- Company also failed Nasdaq's $15M minimum market value of publicly held shares.
- Nasdaq provided 180 calendar days to regain compliance for both requirements.
- Compliance dates are October 13, 2026 (MVLS) and October 14, 2026 (MVPHS).